Historical Control Study of Refractory IFI or Patients Intolerant to Standard Antifungal Therapy in Patients With Invasive Fungal Infections (Study P02387)
NCT00230243 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 330
Last updated 2017-03-10
Summary
This retrospective study is designed to provide a consistent method of screening and collecting data on patients who will serve as controls for a comparison of the efficacy of the available antifungal therapies used as salvage treatments for patients with refractory IFI or for patients with refractory IFI or for patients with IFI who are intolerant to standard antifungal therapies.
Conditions
- Infection, Invasive Fungal
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 13 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1997-03-31
- Primary Completion
- 2002-09-30
- Completion
- 2002-09-30
More Related Trials
-
A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections
NCT00002277 ·Status: COMPLETED ·Phase: PHASE3
-
PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections (Study P01893)
NCT00034671 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common
NCT00002325 ·Status: COMPLETED ·Phase: NA
-
Posaconazole Treatment of Invasive Fungal Infection (IFI) (P05551)
NCT00811642 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Micafungin in Patients With Invasive Candidiasis or Candidemia
NCT00105144 ·Status: COMPLETED ·Phase: PHASE3
-
Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P00041)
NCT00034658 ·Status: COMPLETED ·Phase: PHASE3
-
Optimized Diagnostics for Improved Therapy Stratification in Invasive Fungal Infections
NCT02492594 ·Status: COMPLETED
-
The Role of Interferon-gamma in Immune Responses to Invasive Candidiasis
NCT05235711 ·Status: COMPLETED
-
A Retrospective Study Evaluating the Efficacy and Safety of Micafungin Sodium in the Treatment of Invasive Fungal Infections
NCT02678598 ·Status: COMPLETED
-
Comparative Study of Micafungin (FK463) Versus Placebo as Prophylactic Antifungal Therapy in the ICU
NCT00048750 ·Status: TERMINATED ·Phase: PHASE3
-
Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment
NCT03059992 ·Status: COMPLETED ·Phase: PHASE3
-
Micafungin Salvage Mono-therapy in Invasive Aspergillosis
NCT00376337 ·Status: TERMINATED ·Phase: PHASE2
-
Study to Evaluate the Clinical Outcome in High Risk Patients Who Received Empirical Antifungal Therapy
NCT01439646 ·Status: COMPLETED
-
Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents
NCT01686607 ·Status: COMPLETED
-
Phase II Pilot Study of Fluconazole for Histoplasmosis, Blastomycosis, and Sporotrichosis
NCT00004808 ·Status: COMPLETED ·Phase: PHASE2
-
Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and Candidemia
NCT00189709 ·Status: COMPLETED ·Phase: PHASE3
-
Revision of Antifungal Strategies Definitions for Invasive Fungal Infections in Hematological Malignancies
NCT04024995 ·Status: COMPLETED
-
A Study Of Indian Patients Receiving Therapy For Systemic Fungal Infections
NCT00721578 ·Status: COMPLETED
-
CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension
NCT02734862 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia
NCT01982071 ·Status: TERMINATED ·Phase: PHASE4
-
Outcomes of Patients Who Fail to Respond to Fluconazole Treatment of Severe Candida Albicans Infections
NCT00721487 ·Status: COMPLETED
-
Phase II Study of Fluconazole for Lymphocutaneous and Visceral Sporotrichosis
NCT00004938 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Amphotericin B and Azoles in the Treatment of Invasive Fungal Disease
NCT06819410 ·Status: RECRUITING
-
Study of FK463 in the Treatment of Candidemia or Invasive Candidiasis
NCT00036179 ·Status: COMPLETED ·Phase: PHASE2
-
Anti-fungal Strategies in Acute-on-Chronic Liver Failure Patients
NCT04157465 ·Status: COMPLETED ·Phase: NA